Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Background. Vinorelbine (VRB) and capecitabine (CAPE) are demonstrated to be active in pretreated metastatic breast cancer patients. Different studies have demonstrated that the metronomic treatment is active with an acceptable toxicity profile. We designed a Phases I-II study to define the MTD of o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cazzaniga, M. E., Torri, V., Villa, F., Giuntini, N., Riva, F., Zeppellini, A., Cortinovis, D., Bidoli, P.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2014
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914392/
https://ncbi.nlm.nih.gov/pubmed/24551455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/769790
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires